Safety and efficacy of empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK)

被引：0

作者：

Aamir, A. H. ^{[1
]}

Raja, U. Y. ^{[2
]}

Asghar, A. ^{[3
]}

Mahar, S. A. ^{[4
]}

Ghaffar, T. ^{[5
]}

Ahmed, I. ^{[6
]}

Qureshi, F. M. ^{[7
]}

Zafar, J. ^{[8
]}

Hasan, M. I. ^{[8
]}

Riaz, A. ^{[9
]}

Raza, S. A. ^{[10
]}

Khosa, I. A. ^{[11
]}

Khan, J. ^{[12
]}

Raza, M. ^{[13
]}

Bagar, J. B. ^{[14
]}

机构：

[1] Hayatabad Med Complex, Dept Diabet Endocrinol & Metab Dis, Peshawar, Pakistan

[2] Shifa Int Hosp, Dept Endocrinol, Islamabad, Pakistan

[3] Fatimiyah Hosp, Dept Endocrinol, Karachi, Pakistan

[4] Natl Inst Cardiovasc Dis, Dept Endocrinol, Karachi, Pakistan

[5] Hayatabad Med Complex, Dept Endocrinol, Peshawar, Pakistan

[6] Lady Reading Hosp, Dept Endocrinol, Peshawar, Pakistan

[7] Al Khaliq Hosp, Dept Endocrinol, Lahore, Pakistan

[8] Hanif Med Ctr, Dept Endocrinol, Islamabad, Pakistan

[9] Jinnah Hosp, Lahore, Pakistan

[10] Natl Def Ctr, Lahore, Pakistan

[11] Balochistan Med Ctr, Quetta, Pakistan

[12] Kings Coll London, London, England

[13] Shaheed Zulfikar Ali Bhutto Inst Sci & Technol, Karachi, Pakistan

[14] Univ Karachi, Karachi, Pakistan

来源：

DIABETIC MEDICINE | 2021年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A24 (P187)

引用

页数：2

共 50 条

[21] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes (T2DM)
Kohler, Sven
Salsali, Afshin
Hantel, Stefan
Kim, Gabriel
Woerle, Hans J.
Broedl, Uli C.
[J]. DIABETES, 2015, 64 : A302 - A303
[22] Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
Cho, Yun Kyung
Lee, Jiwoo
Kang, Yu Mi
Yoo, Jee Hee
Park, Joong-Yeol
Jung, Chang Hee
Lee, Woo Je
[J]. PLOS ONE, 2019, 14 (08):
[23] Efficacy and safety of empagliflozin compared with glimepiride in South Asian patients with Type 2 diabetes in a head-to-head study
Khunti, K.
Bingham-Gardiner, P.
Hassan, S. W.
Zeller, C.
Naderali, E.
Salsali, A.
Hach, T.
[J]. DIABETIC MEDICINE, 2015, 32 : 96 - 96
[24] Efficacy and safety of empagliflozin in younger overweight/obese patients with Type 2 diabetes with HbA1c ≥8%
Merker, L.
Lund, S. S.
Hantel, S.
Salsali, A.
Kim, G.
Broedl, U. C.
Woerle, H. J.
Hach, T.
[J]. DIABETIC MEDICINE, 2015, 32 : 90 - 90
[25] EFFICACY AND SAFETY OF EMPAGLIFLOZIN IN ASIAN PATIENTS WITH TYPE 2 DIABETES: POOLED DATA FROM FOUR PHASE III TRIALS
Yoon, K. -H.
Nishimura, R.
Weng, J. P.
Lee, J. S.
Crowe, S.
Salsali, A.
Hach, T.
Woerle, H. J.
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S20 - S21
[26] Efficacy and safety of gemigliptin in patients with type 2 diabetes
Yang, S. J.
Min, K. W.
Park, J. Y.
Kim, D. M.
Kim, Y. S.
Gupta, S. K.
Shivane, V. K.
Pitale, S.
Agarwal, P. K.
Sosale, A. R.
Dharmalingam, M.
Gandhi, P.
Mohan, V.
Kim, J. A.
Baik, S. H.
[J]. DIABETOLOGIA, 2012, 55 : S351 - S352
[27] Efficacy and Safety of Gemigliptin in Patients With Type 2 Diabetes
Yang, Sae Jeong
Min, Kyung Wan
Park, Joong Yeol
Kim, Do-Man
Kim, Yong Seong
Gupta, Sandeep Kumar
Shivane, Vyankatesh K.
Pitale, Shailesh
Agarwal, Pankaj Kumar
Sosale, Aravind R.
Dharmal-Ingam, Mala
Gandhi, Pramod
Mohan, V.
Mahesh, Uma
Kim, Jeong Ae
Kim, Pan Kyung
Baik, Sei Hyun
[J]. DIABETES, 2012, 61 : A594 - A594
[28] THE EFFICACY OF COMBITATION OF EMPAGLIFLOZIN AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
Zhuravlyova, Larysa
Filonenko, Maryna
Rogachova, Tetyana
Sokolnikova, Nelly
[J]. JOURNAL OF HYPERTENSION, 2023, 41 : E194 - E194
[29] The safety of empagliflozin plus metformin for the treatment of type 2 diabetes
Scheen, Andre J.
[J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 837 - 848
[30] Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2-Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes
Anton, Irina Claudia
Mititelu-Tartau, Liliana
Popa, Eliza Gratiela
Poroch, Mihaela
Poroch, Vladimir
Pintilei, Delia Reurean
Botnariu, Gina Eosefina
[J]. HEALTHCARE, 2022, 10 (07)

← 1 2 3 4 5 →